BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20730389)

  • 1. VIPoma syndrome: challenges in management.
    Adam N; Lim SS; Ananda V; Chan SP
    Singapore Med J; 2010 Jul; 51(7):e129-32. PubMed ID: 20730389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.
    Hengst K; Nashan B; Avenhaus W; Ullerich H; Schlitt HJ; Flemming P; Pichlmayr R; Domschke W
    Z Gastroenterol; 1998 Mar; 36(3):239-45. PubMed ID: 9577908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic vipoma arising from colonic primary tumour.
    Bradley C; Haddock G; Pickard RG; Rankin EM
    Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
    Flückiger A; Schlup P
    Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Verner-Morrison syndrome revealing a ganglioneuroblastoma in an adult].
    Neuzillet C; Hammel P; Baudin E; Couvelard A; Elias D; Casiraghi O; Cazals-Hatem D; Pelletier AL; Lévy P; Ruszniewski P
    Gastroenterol Clin Biol; 2008 Mar; 32(3):282-8. PubMed ID: 18403149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VIPomas: an update in diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Safioleas M; Mallas E; Polyzos A
    Hepatogastroenterology; 2005; 52(64):1259-65. PubMed ID: 16001675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation has a valuable therapeutic role in metastatic VIPoma.
    Moug SJ; Leen E; Horgan PG; Imrie CW
    Pancreatology; 2006; 6(1-2):155-9. PubMed ID: 16354964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma.
    Nagorney DM; Bloom SR; Polak JM; Blumgart LH
    Surgery; 1983 Feb; 93(2):348-53. PubMed ID: 6297109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is radiofrequency ablation justified for liver metastatic VIPoma patient undergoing Whipple procedure?
    Li JT; Fang HQ; Liu XL; Tang Z; Xu J; Zhang SZ; Ma R; Zhang LY; Wang JW; Liu YB; Peng SY
    Chin Med J (Engl); 2010 Aug; 123(15):2151-4. PubMed ID: 20819560
    [No Abstract]   [Full Text] [Related]  

  • 10. [W.D.H.A. Syndrome due to occult neuroendocrine malignancy with concomitant liver metastases].
    Rammer M; Kirchgatterer A; Höbling W; Stockhammer M; Knoflach P
    Z Gastroenterol; 2003 Feb; 41(2):185-9. PubMed ID: 12592602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic Vipoma by liver transplantation.
    Bramley PN; Lodge JP; Losowsky MS; Giles GR
    Clin Transplant; 1990 Oct; 4(5 part 1):276-8; discussion 279. PubMed ID: 10150088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surgical and systemic management of neuroendocrine tumors of the pancreas.
    Abood GJ; Go A; Malhotra D; Shoup M
    Surg Clin North Am; 2009 Feb; 89(1):249-66, x. PubMed ID: 19186239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of vasoactive intestinal polypeptideoma.
    Sycamnias J; Strahl B; Stride P; Chern B; Paranavithana L
    N Z Med J; 2009 Jun; 122(1296):64-8. PubMed ID: 19652683
    [No Abstract]   [Full Text] [Related]  

  • 14. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
    Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A long-term survival case of recurrent pancreatic vipoma with liver metastases treated by a combination of surgical resection and loco-regional therapies].
    Matsukawa H; Fujiwara Y; Shiozaki S; Takakura N; Aoki H; Ohno S; Ojima Y; Harano M; Kanazawa T; Choda Y; Ninomiya M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2158-60. PubMed ID: 22202315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
    Butturini G; Bettini R; Missiaglia E; Mantovani W; Dalai I; Capelli P; Ferdeghini M; Pederzoli P; Scarpa A; Falconi M
    Endocr Relat Cancer; 2006 Dec; 13(4):1213-21. PubMed ID: 17158766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastatic malignant vipoma of the pancreas].
    Theissig F; Kunze KD; Schuh D
    Pathologe; 1993 Dec; 14(6):381-5. PubMed ID: 8121895
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
    Williams G; Anderson JV; Williams SJ; Bloom SR
    Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors.
    Song S; Shi R; Li B; Liu Y
    Pancreas; 2009 Oct; 38(7):811-4. PubMed ID: 19657309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
    Berber E; Flesher N; Siperstein AE
    World J Surg; 2002 Aug; 26(8):985-90. PubMed ID: 12016479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.